Ablation procedure
Sponsors
Dhanunjaya Lakkireddy, MD, FACC, Biosense Webster, Inc., Meshalkin Research Institute of Pathology of Circulation, Boston Scientific Corporation, Rush University Medical Center
Conditions
AV Block-2Nd Degree-Type 1ArrhythmiasAtrial FibrillationParoxysmal Atrial FibrillationPersistent Atrial FibrillationSinus PauseVasovagal Syncope
Phase 1
Picasso NAV High-Density Mapping Catheter for Signal Analysis of Complex Arrhythmias - First-In-Man
CompletedNCT02110004
Start: 2014-03-31End: 2014-10-31Updated: 2025-02-03
Comparison of the Ganglionated Plexi Activity in Patients With Different Forms of Atrial Fibrillation Guided by SUMO Technology
NCT02914860
Start: 2016-09-30End: 2017-06-30Target: 60Updated: 2016-09-26
Phase 4
Unknown Phase
FIND CAN Trial: CF-172
CompletedNCT03033641
Start: 2016-12-05End: 2017-08-30Target: 25Updated: 2025-02-03
Electrical Coupling Information From The Rhythmia HDx System And DirectSense Technology In Subjects With Paroxysmal Atrial Fibrillation
CompletedNCT03232645
Start: 2018-01-08End: 2020-08-05Updated: 2021-09-05
Electrical Coupling Information From The RHYTHMIA HDx Mapping System and DIRECTSENSE Technology In The Treatment of Paroxysmal Atrial Fibrillation (LOCALIZE CF)
CompletedNCT04740801
Start: 2021-06-28End: 2022-09-16Updated: 2023-05-11
Cardioneuroablation for Recurrent Vasovagal Syncope and Bradyarrhythmias: The CNA-FWRD Registry
RecruitingNCT06166277
Start: 2024-08-01End: 2027-04-30Target: 300Updated: 2025-09-18
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
RecruitingNCT06324201
Start: 2024-02-27End: 2028-03-31Target: 250Updated: 2025-10-31